Numerous clinical studies have demonstrated that nonsyndromic deafness caused by mutations in the GJB2 gene exhibits diverse clinical phenotypes such as bilateral symmetry, age at onset, degree of deafness, and stability.[117] Therefore, individuals with different mutations within the GJB2 may still require personalized precision gene therapy. This evidence concerns the gene GJB2 and deafness.